Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXAW2T
|
||||
Drug Name |
1-benzylcyclopentyl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate
|
||||
Synonyms |
CHEMBL362134
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H36N2O4
|
||||
Canonical SMILES |
CCCC[C@H](NC(=O)OC1(Cc2ccccc2)CCCC1)C(=O)C(=O)N[C@H](C)c3ccccc3
|
||||
InChI |
InChI=1S/C28H36N2O4/c1-3-4-17-24(25(31)26(32)29-21(2)23-15-9-6-10-16-23)30-27(33)34-28(18-11-12-19-28)20-22-13-7-5-8-14-22/h5-10,13-16,21,24H,3-4,11-12,17-20H2,1-2H3,(H,29,32)(H,30,33)/t21-,24+/m1/s1
|
||||
InChIKey |
RGJSRHUWUYIHPA-QPPBQGQZSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.